Unexpected high rate of early tumor recurrence in patients with HCV-related …

Articles citing Unexpected high rate of early tumor recurrence in patients with HCV-related …

Title / Author	Year
EASL clinical practice guidelines: management of hepatocellular carcinoma European Association For The Study Of The Liver Journal of hepatology 69 (1), 182-236	2018
EASL recommendations on treatment of hepatitis C 2018 European Association for The Study of The Liver Journal of hepatology 69 (2), 461-511	2018
Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases JA Marrero, LM Kulik, CB Sirlin, AX Zhu, RS Finn, MM Abecassis, ... Hepatology 68 (2), 723-750	2018
Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents F Kanwal, J Kramer, SM Asch, M Chayanupatkul, Y Cao, HB El-Serag Gastroenterology 153 (4), 996-1005. e1	2017
Liver cancer cell of origin, molecular class, and effects on patient prognosis D Sia, A Villanueva, SL Friedman, JM Llovet Gastroenterology 152 (4), 745-761	2017
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma GN Ioannou, PK Green, K Berry Journal of hepatology 68 (1), 25-32	2018
2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea AL Shane, RK Mody, JA Crump, PI Tarr, TS Steiner, K Kotloff, JM Langley, ... Clinical Infectious Diseases 65 (12), e45-e80	2017
Hepatitis C virus infection MP Manns, M Buti, ED Gane, JM Pawlotsky, H Razavi, N Terrault, ... Nature reviews Disease primers 3 (1), 1-19	2017
EASL recommendations on treatment of hepatitis C 2018 JM Pawlotsky, F Negro, A Aghemo, M Berenguer, O Dalgard, G Dusheiko, ... Journal of hepatology 69 (2), 461-511	2018
Epidemiology and management of hepatocellular carcinoma L Kulik, HB El-Serag Gastroenterology 156 (2), 477-491. e1	2019
Direct‐acting antivirals for chronic hepatitis C JC Jakobsen, EE Nielsen, J Feinberg, KK Katakam, K Fobian, G Hauser, ... Cochrane Database of Systematic Reviews	2017
Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy PC Tsai, CF Huang, ML Yu Journal of hepatology 66 (2), 464	2017
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches G Sapisochin, J Bruix Nature reviews Gastroenterology & hepatology 14 (4), 203-217	2017
A global view of hepatocellular carcinoma: trends, risk, prevention and management JD Yang, P Hainaut, GJ Gores, A Amadou, A Plymoth, LR Roberts Nature reviews Gastroenterology & hepatology, 1-16	2019
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort JL Calleja, J Crespo, D Rincón, B Ruiz-Antorán, I Fernandez, C Perelló, ... Journal of hepatology 66 (6), 1138-1148	2017
Impact of sustained virologic response with direct‐acting antiviral treatment on mortality in patients with advanced liver disease LI Backus, PS Belperio, TA Shahoumian, LA Mole Hepatology 69 (2), 487-497	2019
Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma LA Beste, PK Green, K Berry, MJ Kogut, SK Allison, GN Ioannou Journal of hepatology 67 (1), 32-39	2017
Direct antiviral agents (DAAs)-A new age in the treatment of hepatitis C virus infection U Spengler Pharmacology & therapeutics 183, 118-126	2018
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals TF Baumert, F Jühling, A Ono, Y Hoshida BMC medicine 15 (1), 52	2017
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study G Cabibbo, S Petta, V Calvaruso, I Cacciola, MR Cannavò, S Madonia, ... Alimentary pharmacology & therapeutics 46 (7), 688-695	2017

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.